| Literature DB >> 34741121 |
Marek Drobniewski1, Marek Synder1, Marek Aleksander Synder1, Magdalena Krasińska1, Lukasz Olewnik2, Andrzej Borowski3.
Abstract
The aim of the study was to analyse the results of uncemented total hip replacement, using the Metha (metaphyseal) stem. A total of 158 patients (70 females and 88 males) were qualified to the study and submitted to total hip arthroplasty (183 procedures altogether), using the Metha stem. The mean age of the patients on the day of surgery was 51.7 years (the range from 17 to 69 years). The mean follow up period was 9.2 years (the range from 5 to 13.5 years). Preoperative assessments gave poor scores, according to the Merle d'Aubigne and Postel classification, modified by Charnley. The average improvement after surgery, according to the used scale, was 6.9 points. A very good outcome was recorded in 154 cases (84.2%), a good outcome was achieved in 20 cases (10.9%) and a poor outcome was confirmed in 9 cases, while no satisfactory case was observed. Poor outcomes were associated with implant loosening. Extraskeletal ossification was noted in 10 cases (5.5%). According to the Kaplan-Meier estimator, the 10-year survival was 93.2% and 97.3% for the whole implant and the stem alone, respectively. 1. Our follow-up period of more than 9 years on the average, indicates that Metha stems produce excellent clinical and functional results in operated young patients with advanced degenerative changes of the hip joint. 2. Assuming a proper qualification for the procedure, the absence of complications and a correct surgical technique, which is slightly more difficult, when compared to standard stem implantation, the risk of aseptic loosening is fairly negligible.Entities:
Mesh:
Year: 2021 PMID: 34741121 PMCID: PMC8571394 DOI: 10.1038/s41598-021-01367-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Characteristic features of the study group, divided by gender.
| Women | Men | Total number | |
|---|---|---|---|
| The number of patients in the group | 70 (44.3%) | 88 (55.7%) | 158 |
| The number of operations | 84 (45.9%) | 99 (54.1%) | 183 |
| Right hip joint | 48 (51.6%) | 45 (48.4%) | 93 |
| Left hip joint | 36 (40%) | 54 (60%) | 90 |
| Two-stage procedure—left and right hip | 14 (56%) | 11 (44%) | 25 |
| The mean age of the patients on the day of surgery | 51.3 years | 52.0 years | 51.7 years |
| Min. | 20 years | 17 years | 17 years |
| Max. | 69 years | 69 years | 69 years |
| The mean follow up period | 3401 days (9.3 years) | 3306.9 days (9.1 years) | 3350.1 days (9.2 years) |
| Min. | 1837 days (5 years) | 1884 days (5.2 years) | 1837 days (5 years) |
| Max. | 4949 days (13.5 years) | 4949 days (13.5 years) | 4949 days (13.5 years) |
Revision surgery both for acetabular and femoral failure.
| No. | Patient | Sex | Age | OA etiology | Side | Primary surgery date | Revision surgery day | Period of biofunctionality (days) | Type of the implant that was revised | Type of the implant that was re-implanted |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | K. R | M | 53 | Idiopathic | Right | 16.06.2008 | 14.09.2016 | 3012 | Insert PLASMACUP | Insert PLASMACUP |
| 2 | W. N | M | 55 | AVN | Left | 27.07.2009 | 25.05.2011 | 667 | Stem METHA | Stem ANTEGA |
| 3 | M. P | F | 55 | Idiopathic | Left | 06.08.2009 | 07.08.2019 | 3653 | Acetabular cup SCREWCUP | Acetabular cup PE-Cup |
| 4 | W. N | M | 56 | AVN | Right | 24.02.2010 | 10.10.2012 | 959 | Stem METHA | Stem ANTEGA |
| 5 | K. K | F | 64 | Idiopathic | Left | 30.06.2010 | 04.09.2019 | 3353 | Insert PLASMACUP | Insert PLASMACUP |
| 6 | L. S | F | 53 | Idiopathic | Right | 05.04.2013 | 15.04.2013 | 10 | Acetabular cup PLASMACUP | Acetabular cup PLASMACUP |
| 7 | K. R | M | 58 | Idiopathic | Right | 08.10.2013 | 16.08.2018 | 1773 | Acetabular cup PLASMACUP | Insert PLASMACUP |
| 8 | A. S | F | 42 | DDH | Left | 04.08.2014 | 07.11.2016 | 826 | Acetabular cup SCREWCUP | Acetabular cup PLASMAFIT |
| 9 | D. G | KF | 48 | DDH | Right | 01.12.2014 | 24.04.2009 | 2047 | Acetabular cup PLASMACUP | Acetabular cup AVANTAGE |
Data containing patients: gender, age, OA etiology, date of revision, type of the implant that was revised.
OA osteoarthritis.
Clinical results by the modified Merle d’Aubigne and Postel's (MAP) grading, with consideration of the aetiology of degenerative changes.
| Aetiology | MAP outstanding | MAP good | MAP satisfactory | MAP poor |
|---|---|---|---|---|
| Idiopathic (146 hips) | 126 | 11 | 0 | 9 |
| AVN (23 hips) | 20 | 3 | 0 | 0 |
| DDH (14 hips) | 8 | 6 | 0 | 0 |
| 154 (84.2%) | 20 (10.9%) | 0 (0%) | 9 (4.9%) |
AVN avascular necrosis of the femoral head, DDH developmental dysplasia of the hip.
Kaplan–Meier biofunctionality coefficients for installed implants after 5 and 10 years from the surgery.
| Kaplan–Meier coefficients after 5 years (183 hips) | Kaplan–Meier coefficients after 10 years (74 hips) | |
|---|---|---|
| The entire implant | 95.0819% (91.8688–98.2950) | 93.2432% (87.3206–99.1658) |
| The cup | 96.1748% (93–3411-99.0085) | 95.9459% (91.3583–100.5335) |
| The Metha stem | 98.9071% (97.3924–100.4217) | 97.2972% (93.5515–101.0430) |